SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016204
Filing Date
2024-06-10
Accepted
2024-06-10 16:19:29
Documents
1
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 form4-06102024_080625.html 4  
1 form4-06102024_080625.xml 4 4138
  Complete submission text file 0001415889-24-016204.txt   5666
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NEW LEAF VENTURE PARTNERS 1200 PARK PLACE, SUITE 300 SAN MATEO CA 94043
Business Address
Dybbs Michael (Reporting) CIK: 0001601264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 241032991